Sells medication dispensing and pharmacy automation systems, software, and services to hospitals, health systems, and pharmacies.
10-K for FY2025, filed Feb 26, 2026Our products and services span the evolving continuum of care, including inpatient, outpatient, and retail settings. We provide a range of…View ↗
Hospital and Health System Solutions: This category enables the end-to-end medication process across the entire continuum of care. It…View ↗
Our EnlivenHealth brand extends beyond the inpatient setting and into ambulatory care. This brand offers a portfolio of products designed…View ↗
Healthcare facilities buy connected devices and software, invoiced when products ship and completed after installation and customer acceptance. Support and software services are billed monthly, quarterly, or annually over contract terms; invoices are generally due 30 to 60 days after shipment or services are performed.
10-K for FY2025, filed Feb 26, 2026Connected devices, software licenses, and other. Software-enabled connected devices and software licenses that manage and regulate the…View ↗
Revenue Category Timing of Revenue Recognition Income Statement Classification Connected devices, software licenses, and other Point in…View ↗
The entity can identify the payment terms for the goods or services to be transferred. Payment terms are documented within the agreement…View ↗
The Company generally invoices customers for products upon shipment. Invoicing associated with the service portion of agreements is…View ↗
The amount invoiced for equipment and software is typically reflected in both accounts receivable and deferred revenues. The Company…View ↗
10-K for FY2025, filed Feb 26, 2026
FY2025 revenue by product or service ↗$1.2B
10-K for FY2025, filed Feb 26, 2026
$1.2B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Connected devices, software licenses, and other
Sold outright
10-K for FY2025, filed Feb 26, 2026 |
48%
FY2022: 64%
|
Connected devices, software licenses, and other, FY2025
$565.5M Sources
|
Sold outright |
|
Consumables
Sold outright
|
8.5%
FY2022: 5.8%
|
Consumables, FY2025
$100.2M Sources
|
Sold outright |
|
Technical services
Recurring
10-K for FY2025, filed Feb 26, 2026 |
22%
FY2022: 16%
|
Technical services, FY2025
$260.1M Sources
|
Recurring |
|
SaaS and Expert Services
Mix
10-K for FY2025, filed Feb 26, 2026 |
22%
FY2022: 14%
|
SaaS and Expert Services, FY2025
$259.1M Sources
|
Mix |
Hospitals, health systems, pharmacies, and other healthcare providers buy Omnicell’s systems and services. Sales in the United States and Canada are primarily direct; some Canadian consumables and automation, and sales in many international markets, go through distributors.
10-K for FY2025, filed Feb 26, 2026
Yes. It kept less than a cent of every revenue dollar as net income in FY2025 and turned 7 cents into free cash flow.
10-K for FY2025, filed Feb 26, 2026
$5.2MView ↗
10-K for FY2025, filed Feb 26, 2026
$2.1MView ↗
10-K for FY2025, filed Feb 26, 2026
$86.9MView ↗
10-Q for Q2 FY2026, filed Aug 5, 2026
Open tableView ↗
8-K, filed Jul 30, 2026
On July 30, 2026, Omnicell, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30…View ↗
Flat. Revenue was $1.2B in FY2025, about the same as the $1.1B of FY2021.
Loading...